Optimal Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Optimal Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.54M	Buy	76,711 +85	+0.1%	+$5.6K	0.57%	47
2021 Q2	$5.12M	Hold	76,626	–	–	0.61%	37
2021 Q1	$4.84M	Buy	76,626 +38,701	+102%	+$2.41M	0.63%	37
2020 Q4	$2.35M	Hold	37,925	–	–	0.33%	94
2020 Q3	$2.29M	Buy	37,925 +17,357	+84%	+$1.04M	0.33%	97
2020 Q2	$1.21M	Buy	20,568 +4,002	+24%	+$239K	0.2%	171
2020 Q1	$923	Buy	16,566 +11,936	+258%	+$730K	0.09%	296
2019 Q4	$297K	Buy	+4,630	New	+$265K	0.05%	370

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Optimal Asset Management's BMY Position: Q3 2021 in Review

Optimal Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.11% in Q3 2021, buying an estimated $5.6K and bringing the position to 76,711 shares worth $4.54M. The position accounts for 0.57% of the portfolio, ranked #47.

Optimal Asset Management first reported a position in BMY in Q4 2019 and has held it in 8 quarters since. The position peaked at $5.12M in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Optimal Asset Management held 76,711 shares of Bristol-Myers Squibb worth $4.54M as of Q3 2021.
Optimal Asset Management bought 85 Bristol-Myers Squibb shares in Q3 2021, an estimated $5.6K.
Bristol-Myers Squibb made up 0.57% of Optimal Asset Management's portfolio in Q3 2021, its #47 holding.
Optimal Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 8 quarters since.
Optimal Asset Management's Bristol-Myers Squibb position peaked at $5.12M in Q2 2021.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.